Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
Hold with a pointer, or hold Space or Enter.
News
Definium Therapeutics advances in pivotal study with fresh Phase 3 anxiety data
5+ hour, 57+ min ago (677+ words) Traders Union Definium Therapeutics advances in pivotal study with fresh Phase 3 anxiety data Definium Therapeutics reported positive topline results from its first Phase 3 clinical trial, Voyage, evaluating DT120 ODT for generalized anxiety disorder. This marks the companys second consecutive positive pivotal…...